These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35409328)

  • 1. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
    Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
    BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
    Alam MS; Sultana A; Reza MS; Amanullah M; Kabir SR; Mollah MNH
    PLoS One; 2022; 17(5):e0268967. PubMed ID: 35617355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
    Andalib KMS; Rahman MH; Habib A
    J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis.
    Hossen MA; Reza MS; Harun-Or-Roshid M; Islam MA; Siddika MA; Mollah MNH
    Curr Cancer Drug Targets; 2023; 23(7):547-563. PubMed ID: 36786134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer.
    Alam MS; Sultana A; Wang G; Haque Mollah MN
    Front Mol Biosci; 2022; 9():1049741. PubMed ID: 36567949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer.
    Alam MS; Rahaman MM; Sultana A; Wang G; Mollah MNH
    Comput Biol Med; 2022 Jun; 145():105508. PubMed ID: 35447458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer.
    Hossen MB; Islam MA; Reza MS; Kibria MK; Horaira MA; Tuly KF; Faruqe MO; Kabir F; Mollah MNH
    Comput Biol Med; 2023 Jan; 152():106411. PubMed ID: 36502691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
    Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.
    Reza MS; Hossen MA; Harun-Or-Roshid M; Siddika MA; Kabir MH; Mollah MNH
    Discov Oncol; 2022 Aug; 13(1):79. PubMed ID: 35994213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods.
    Wang D; Liu Y; Cheng S; Liu G
    Med Sci Monit; 2022 Apr; 28():e934799. PubMed ID: 35428744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.
    Ajadee A; Mahmud S; Hossain MB; Ahmmed R; Ali MA; Reza MS; Sarker SK; Mollah MNH
    PLoS One; 2024; 19(9):e0310843. PubMed ID: 39348357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive identification of potential molecular targets and small drugs candidate for melanoma cancer using bioinformatics and network-based screening approach.
    Khan DA; Adhikary T; Sultana MT; Toukir IA
    J Biomol Struct Dyn; 2024 Sep; 42(14):7349-7369. PubMed ID: 37534476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer.
    Alam MS; Sultana A; Sun H; Wu J; Guo F; Li Q; Ren H; Hao Z; Zhang Y; Wang G
    Front Pharmacol; 2022; 13():942126. PubMed ID: 36204232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 18. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
    Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
    Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.